Lipocine's total assets for Q4 2024 were $22.51M, an increase of 8.76% from the previous quarter. LPCN total liabilities were $1.51M for the fiscal quarter, a -4.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.